DoJ Bull’s Eye: Off-Label Promotion, Formulary Placements, FCPA Violations Remain Targets
Executive Summary
A Pfizer attorney says government saber rattling over individual liability does not mean there will be a spike in individual prosecutions; Pfizer’s cooperation with the government helped it avoid criminal resolution in a Foreign Corrupt Practices Act settlement.
You may also be interested in...
Pfizer Settles Foreign Bribery Charges With Prosecution Deferred
Pfizer settles with DoJ and SEC to resolve charges its subsidiaries bribed foreign government officials; a subsidiary enters a deferred prosecution agreement with DoJ. In a separate case, Pfizer’s Wyeth subsidiary agrees to pay $18.9 million in disgorgement of net profits and prejudgment interest to SEC.
Pfizer Settles Foreign Bribery Charges With Prosecution Deferred
Pfizer settles with DoJ and SEC to resolve charges its subsidiaries bribed foreign government officials; a subsidiary enters a deferred prosecution agreement with DoJ. In a separate case, Pfizer’s Wyeth subsidiary agrees to pay $18.9 million in disgorgement of net profits and prejudgment interest to SEC.
Pfizer Settles Foreign Bribery Charges, Wins Deferred Prosecution For Helping Government
Pfizer reaches separate settlements with U.S. DoJ and SEC to resolve charges its subsidiaries bribed Chinese, Russian and other foreign government officials; a subsidiary enters a deferred prosecution agreement with DoJ.